Showing results (31-40 of 92) with videos related to
Sort By:
Pageof 10
CNS Drugs|June 7, 2012
A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injuryKevin W McConeghy, Jimmi Hatton, Lindsey Hughes, et al.Shock (Augusta, Ga.)|November 3, 2021
Azithromycin and Major Adverse Kidney Events in Critically Ill Patients With Sepsis-Associated Acute Kidney InjuryMichael L Behal, Jonny L Nguyen, Xilong Li, et al.Circulation|April 9, 2020
Factor Xa Inhibitor-Related Intracranial Hemorrhage: Results From a Multicenter, Observational Cohort Receiving Prothrombin Complex ConcentratesNicholas G Panos, Aaron M Cook, Sayona John, et al.Journal of Neurosurgery|December 2, 2017
Management of antiplatelet therapy in patients undergoing neuroendovascular proceduresKeri S Kim, Justin F Fraser, Stephen Grupke, et al.Pediatric Neurosurgery|June 9, 2005
Linezolid for the treatment of a heteroresistant Staphylococcus aureus shunt infectionAaron M Cook, Christian N Ramsey, Craig A Martin, et al.The Annals of Pharmacotherapy|November 13, 2008
Rash associated with pregabalin useTimothy L Smith, Aaron Baldwin, Larry L Cunningham, et al.Antimicrobial Agents and Chemotherapy|May 18, 2011
Pharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adultsAaron M Cook, Craig Martin, Val R Adams, et al.Pharmacotherapy|March 31, 2023
Personalized antiseizure medication therapy in critically ill adult patientsSulaiman Almohaish, Aaron M Cook, Gretchen M Brophy, et al.Frontiers in Nephrology|December 12, 2022
Progression of Kidney Injury with the Combination of Vancomycin and Piperacillin-Tazobactam or Cefepime in Sepsis-Associated Acute Kidney InjuryKaylee Whitenack, Michael L Behal, Melissa L Thompson Bastin, et al.Pharmacotherapy|July 27, 2010
Pharmacologic options for reducing the shivering response to therapeutic hypothermiaKyle A Weant, Julia E Martin, Roger L Humphries, et al.Pageof 10